Hippocratic AI announced it has raised $126 million in Series C funding at a $3.5 billion valuation, led by Avenir Growth with participation from CapitalG, General Catalyst, Andreessen Horowitz, and others. This brings the company’s total funding to $404 million. The investment will support expansion, mergers and acquisitions, product development, and international growth as the company continues to scale its safety-focused generative AI healthcare agents.
In just 15 months since commercialization, Hippocratic AI has established partnerships with over 50 major health systems, payors, and pharmaceutical clients across 6 countries. The company has built over 1,000 clinical use cases and completed more than 115 million clinical patient interactions with no safety issues. Partners include Cleveland Clinic, Northwestern Medicine, Sheba Medical Center, and many other leading healthcare organizations that have praised Hippocratic AI’s commitment to clinical safety, empathy, and reliable patient care delivery.